SARS-CoV-2 Innate immunity evasion mechanisms and cell-specific immune responses; Metabolic overview over ATII cells infectionc4eBasiginGM-CSFTIM3Caspase-8Binds to 5' PPP RNA regionPba1c4ea88c4ec4ebbcf42c4ebbcbbcc4ec1fc6de56Immunoglobulin A (IgA) can bind to the S1 domain of the SARS-CoV-2 spike protein leading to an early burst of IgA that may eliminate the virus in the respiratory mucosa and prevent the development of full adaptive immune response.e5dc4ebbcc4ec6dc4eImmunolobulin M can bind to the RBD of the S1 domain of the SARS-CoV-2, acting as primary immune response.Type your comment heree5dc4ebbcbbcbbcbbcdd1bbcec1bbcc96c58bbca88c4ec4eba1a88c4edd1d77c71ba8bbcbbcThe increase of TGFß production induces the IgA isotype switch.e5dbbcc04bbcHigh levels of viral load stimulate TGFß production, which is locally secreted.e5dc4eTGF-beta signalling pathway enhanced; Observed in SARS-CoV hypothesises to be conserved in SARS-CoV-2bbcc4eaedbbcec1c4eba1c4eba1bbcbbcbbcc4ebbcc4ec4ec96Including MX1, IFTM1, IFIT232529952PubMedSARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.Emerg. Microbes Infect.2020Yuen, C. K.Lam, J. Y.Wong, W. M.Mak, L. F.Wang, X.Chu, H.et al.32353859PubMedA SARS-CoV-2 protein interaction map reveals targets for drug repurposingNature2020Gordon, D. E.Jang, G. M.Bouhaddou, M.Xu, J.Obernier, K.White, K. M.et al.32353859PubMedA SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020Gordon DEJang GMBouhaddou MXu JObernier KWhite KMO'Meara MJRezelj VVGuo JZSwaney DLTummino TAHüttenhain RKaake RMRichards ALTutuncuoglu BFoussard HBatra JHaas KModak MKim MHaas PPolacco BJBraberg HFabius JMEckhardt MSoucheray MBennett MJCakir MMcGregor MJLi QMeyer BRoesch FVallet TMac Kain AMiorin LMoreno ENaing ZZCZhou YPeng SShi YZhang ZShen WKirby ITMelnyk JEChorba JSLou KDai SABarrio-Hernandez IMemon DHernandez-Armenta CLyu JMathy CJPPerica TPilla KBGanesan SJSaltzberg DJRakesh RLiu XRosenthal SBCalviello LVenkataramanan SLiboy-Lugo JLin YHuang XPLiu YWankowicz SABohn MSafari MUgur FSKoh CSavar NSTran QDShengjuler DFletcher SJO'Neal MCCai YChang JCJBroadhurst DJKlippsten SSharp PPWenzell NAKuzuoglu-Ozturk DWang HYTrenker RYoung JMCavero DAHiatt JRoth TLRathore USubramanian ANoack JHubert MStroud RMFrankel ADRosenberg OSVerba KAAgard DAOtt MEmerman MJura Nvon Zastrow MVerdin EAshworth ASchwartz Od'Enfert CMukherjee SJacobson MMalik HSFujimori DGIdeker TCraik CSFloor SNFraser JSGross JDSali ARoth BLRuggero DTaunton JKortemme TBeltrao PVignuzzi MGarcía-Sastre AShokat KMShoichet BKKrogan NJsevere acute respiratory syndromeDOID:2945Disease33391280PubMedDifferent Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.Front Immunol2020Carsetti RZaffina SPiano Mortari ETerreri SCorrente FCapponi CPalomba PMirabella MCascioli SPalange PCuccaro IMilito CZumla AMaeurer MCamisa VVinci MRSantoro ACimini EMarchioni LNicastri EPalmieri FAgrati CIppolito GPorzio OConcato COnetti Muda ARaponi MQuintarelli CQuinti ILocatelli F10.1101/2020.03.14.988345DOISARS-CoV2 invades host cells via a el route: CD147-spike proteinbioRxiv2020Wang KChen WZhou Y-SLian J-QZhang ZDu Pet al.32555321PubMedThe ORF3a protein of SARS-CoV-2 induces apoptosis in cells.Cell Mol Immunol2020Ren YShu TWu DMu JWang CHuang MHan YZhang XYZhou WQiu YZhou X33372174PubMedSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signalingbioRxiv2020Zheng Y.Zhuang M-W.Han L.Zhang J.Nan M-L.Gao C.et al.33335518PubMedCOVID-19: The Emerging Immunopathological Determinants for Recovery or Death.Front Microbiol2020Ahmad TChaudhuri RJoshi MCAlmatroudi ARahmani AHAli SM32529952PubMedSARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonistsEmerg Microbes Infect.2020Chun-Kit YuenJoy-Yan LamWan-Man WongLong-Fung MakXiaohui WangHin ChuJian-Piao CaiDong-Yan JinKelvin Kai-Wang ToJasper Fuk-Woo ChanKwok-Yung YuenKin-Hang Kok31986264PubMedClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet2020Huang, C.Wang, Y.Li, X.Ren, L.Zhao, J.Hu, Y.et al.10.1101/2020.08.03.234559DOISARS-CoV-2 ORF6 disrupts nucleocytoplasmic transport through interactions with Rae1 and Nup98bioRxiv2020Addetia, A.Lieberman, N. P.Phung, Q.Xie, H.Roychoudhury, P.Loprieno, M. A.et al.33335518PubMedCOVID-19: The Emerging Immunopathological Determinants for Recovery or Death.Front Microbiol2020Ahmad TChaudhuri RJoshi MCAlmatroudi ARahmani AHAli SM26579391PubMedRecent advances in the anti-HCV mechanisms of interferon.Acta Pharm Sin B2014Huang MJiang JDPeng Z32353859PubMedA SARS-CoV-2 protein interaction map reveals targets for drug repurposingNature2020Gordon, D. E.Jang, G. M.Bouhaddou, M.Xu, J.Obernier, K.White, K. M.et al.10.1101/2020.04.19.20068015DOIImpaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients.medRxiv2020Hadjadj, J.Yatim, N.Barnabei, L.Corneau, A.Boussier, J.Pere, H.et aldisease pathwayPW:0000013Pathway Ontology33335518PubMedCOVID-19: The Emerging Immunopathological Determinants for Recovery or Death.Front Microbiol2020Ahmad TChaudhuri RJoshi MCAlmatroudi ARahmani AHAli SM15580300PubMedInterferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.Oncogene2005Porta CHadj-Slimane RNejmeddine MPampin MTovey MGEspert LAlvarez SChelbi-Alix MK17490702PubMedNucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB.VirologyZhang XWu K.Wang D.Yue X.Song D.Zhu Y.et al.33101306PubMedCovid-19: Perspectives on Innate Immune Evasion.Front Immunol2020Taefehshokr NTaefehshokr SHemmat NHeit B32416070PubMedImbalanced host response to SARS-CoV-2 drives development of COVID-19Cell2020Blanco-Melo, D.Nilsson-Payant, B. E.Liu, W. C.Uhl, S.Hoagland, D.Møller,
R.et al.33335518PubMedCOVID-19: The Emerging Immunopathological Determinants for Recovery or Death.Front Microbiol2020Ahmad TChaudhuri RJoshi MCAlmatroudi ARahmani AHAli SM10.2139/ssrn.3555695DOIViral invasion and Type I interferon response characterize the immunophenotypes during COVID-19 infectionEpub ahead of print2020Wei, L.Ming, S.Zou, B.Wu, Y.Hong, Z.Li, Z.et al.COVID-19DOID:0080600Diseaseimmune response pathwayPW:0000023Pathway Ontology19430490PubMedCoronaviruses post-SARS: update on replication and pathogenesisNat Rev Microbiol.2009Stanley PerlmanJason Netland